Management of childhood idiopathic thrombocytopenic purpura: A survey of members of the French Society of Pediatric Hematology and Immunology (SHIP);La prise en charge du purpura thrombopénique idiopathique en phase initiale : enquête auprès des membres de la Société française d'hématologie et d'immunologie pédiatrique (SHIP)

Archives de Pediatrie

Volumn 14, Issue 5, 2007, Pages 444-449

  Lutz, P ^a   Villega, F ^a   Ducassou, S ^a   Entz Werle, N ^a   Michel, G ^b  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

Child; Idiopathic thrombocytopenic purpura

Indexed keywords

IMMUNOGLOBULIN; PREDNISONE; CORTICOSTEROID;

ARTICLE; CHILDHOOD DISEASE; CONTROLLED STUDY; HEALTH SERVICE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MEDICAL SOCIETY; PRESCRIPTION; PUBLICATION; QUESTIONNAIRE; CHILD; CLINICAL PRACTICE; FRANCE; STATISTICS;

ADRENAL CORTEX HORMONES; CHILD; FRANCE; HOSPITALIZATION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PHYSICIAN'S PRACTICE PATTERNS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; QUESTIONNAIRES; SOCIETIES, MEDICAL;

EID: 34247567132     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2006.12.005     Document Type: Article

References (14)

1. Kuhne T., Imbach P., Bolton-Maggs P.H.B., et al. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet 358 (2001) 2122-2125
2. Vesely S.K., Buchanan G.R., Adix L., et al. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J. Pediatr. Hematol. Oncol. 25 (2003) 130-133
3. Bolton-Maggs P.H., and Moon I. National audit of the management of childhood idiopathic thrombocytopenic purpura against UK guidelines: closing the loop: education and re-audit demonstrate a change in practice. Blood 98 (2001) 58b
4. Eden O.B., and Lilleyman J.S. The British Paediatric Haematology Group. Guidelines for management of idiopathic thrombocytopenic purpura. Arch. Dis. Child. 67 (1992) 1056-1058
5. Dickerhoff R., and Von Ruecker A. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment. J. Pediatr. 137 (2000) 629-632
6. Marks M.K., Vadamalayan B., Ekert H., et al. Intended management of children with acute idiopathic thrombocytopenic purpura: a national survey. J. Paediatr. Child Health 41 (2005) 52-55
7. Rosthoj S., Hedlund-Treutiger I., Rajantie J., et al. Duration and morbitidy of newly diagnosed idiopathic thrombocytopenic purpura in children: a prospective nordic study of an unselected cohort. J. Pediatr. 143 (2003) 302-307
8. Tarantino M. Recent advances in the treatment of childhood immune thrombocytopenic purpura. Semin. Hematol. 43 3 Suppl 5 (2006) S11-S17 (discussion: S18-9)
9. Blanchette V., Imbach P., Andrew M., et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 344 (1994) 703-707
10. Benesch M., Kerbl R., Lackner H., et al. Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial. J. Pediatr. Hematol. Oncol. 25 (2003) 797-800
11. Beck C.E., Nathan P.C., Parkin P.C., et al. Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials. J. Pediatr. 147 (2005) 521-527
12. George J.N., Woolf S.H., Raskob G.E., et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for The American Society of Hematology. Blood 88 (1996) 3-40
13. Kühne T., Buchanan G.R., Zimmerman S., et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J. Pediatr. 143 (2003) 605-608
14. O'Brien S.H., Ritchey A.K., and Smith K.J. A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP). Pediatr. Blood Cancer (2006)